FDA Approves Sarclisa for Certain Patients with Multiple Myeloma

Estimated read time 1 min read

The drug is approved for newly diagnosed patients not eligible for transplant and is to be used in combination with standard-of-care treatment.

You May Also Like

More From Author

+ There are no comments

Add yours